Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

HIV, hepatitis B and C and TB can each be treated for less than $90 a year where generic drugs can be made available, Dzintars Gotham of Imperial College, London, reported at the 9th International AIDS Society Conference on HIV Science in Paris.

To read the full article, click here.

Source: Aidsmap

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Keith Alcorn

Published: July 27, 2017, 11:38 a.m.

Last updated: July 27, 2017, 11:40 a.m.

Tags: Treatment, Access

Print Share